CD8A and hepatocellular carcinoma: Multiple lines of evidence suggest a significant upregulation of PD-1 expression on CD8+ T cells in all clinical phases of HBV infection, encompassing AHB, CHB, HCC, and acute-on-chronic liver failure (ACLF) (146–148).